Peer Review History
| Original SubmissionDecember 20, 2022 |
|---|
|
PONE-D-22-28187Effectiveness and feasibility of structured emotionally focused family therapy for parents and adolescents: Protocol of a within-subjects pilot studyPLOS ONE Dear Dr. Conradi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Specifically, much more detail is requested regarding the protocol and outcome measures. Please submit your revised manuscript by Mar 11 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Kymberly D. Young, Ph.D. Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf 2. Thank you for stating the following in the Competing Interests section: “PD is member of the board of EFT Netherlands. LR provides EFFT. The other authors declare that they have no competing interests.” Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: ""This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf. 3. Please ensure that you include a title page within your main document. You should list all authors and all affiliations as per our author instructions and clearly indicate the corresponding author. 4. Please amend your authorship list in your manuscript file to include author list. 5. We note that the original protocol file you uploaded contains a confidentiality notice indicating that the protocol may not be shared publicly or be published. Please note, however, that the PLOS Editorial Policy requires that the original protocol be published alongside your manuscript in the event of acceptance. Please note that should your paper be accepted, all content including the protocol will be published under the Creative Commons Attribution (CC BY) 4.0 license, which means that it will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. Therefore, we ask that you please seek permission from the study sponsor or body imposing the restriction on sharing this document to publish this protocol under CC BY 4.0 if your work is accepted. We kindly ask that you upload a formal statement signed by an institutional representative clarifying whether you will be able to comply with this policy. Additionally, please upload a clean copy of the protocol with the confidentiality notice (and any copyrighted institutional logos or signatures) removed. 6. We note that the original protocol that you have uploaded as a Supporting Information file contains an institutional logo. As this logo is likely copyrighted, we ask that you please remove it from this file and upload an updated version upon resubmission. 7. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. Additional Editor Comments: The reviewer asks for much more detail about the protocol and measures. Additionally, please address the following in your response: Why was a RCT deemed not feasible for the pilot study? A between group comparison to the unmodified therapy would be a much stronger design. Do these modifications add any benefit? I believe this is a key question that is unanswered by the current design. There are multiple follow-up measures, but it is unclear what the primary outcome is. Please clarify and justify. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field. Reviewer #1: Partly ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses? The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory. Reviewer #1: Partly ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable? Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible. Reviewer #1: No ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Reviewers comments The protocol article presents a promising study within a growing field. The authors present a good rationale for their study and describe the study and the method fairly well. However, I have some comments. The reasons for my answers to the questions above are stated here. 1. Please be consistent throughout the manuscript regarding how many time points you are going to collect data at. It looks as if you first argue for three, then five, and in Table 1, I find six. 2. In the second sentence, you mention anger as a diagnostic category. Anger is definitely an important emotion. However, it is not a diagnosis in the DSM-5 or ICD-10. 3. I would like a reference the first time EFFT is introduced. Further, since there is another EFFT that seems to be very much like this one (both are presented in the book you refer to, actually in the following chapter, and both have almost identical names), I would like a comment so that there is no confusion as to which of the EFFTs you are planning to investigate, and thus provide a reason for why you are not referring to any of the studies of the other EFFT, which has several studies to refer to. 4. Please state more clearly that the structured EFFT you are to study differs from EFFT as described by the inventor and is thus something you have constructed. 5. Please provide a reason why this type of EFFT can be applied to parents and their children aged six and older. Why not younger? 6. On page 4, you mention the newly developed protocol of structured EFFT. Please mention there that it is provided further down in the manuscript. 7. Hypotheses: The first one (no, or less change) is two different hypotheses. 8. Method section. The last sentence in the first paragraph of the passage "design": "we will get a clear impression." Please restate. You do not know for sure that it will provide a clear impression. 9. Same passage: you state: "treatment protocol by the therapists will be based on structured observation checklists." I cannot find those structured checklists. 10. Participant section: it is not clear from the first sentence who will be included. I find it possible to read that you plan two groups. one with adolescents (12–18) and another one with families coping with mild problems. 11. Participant section. You write, "(c) families of which the parents or children are diagnosed with severe DSM disorders (substance abuse or psychosis) or are in therapy." I don't think it's fair to exclude parents and children with severe DSM diagnoses, as well as anyone in therapy for any reason. Please clarify. 12. Procedure and assessments section: You write, "to ensure 100% response rate to the other assessments, respondents will gather in the therapist’s room 20 minutes prior to the specific session to complete the questionnaires." This will not ensure a 100% response, but it will make it more probable. 13. Instruments section: You state in your description of the RDS that one unpublished study found a Chronbach's alpha of 72. That is an acceptable value, but not a good one. However, since the study is not yet published, it is not clear if that is related to the reworded version used in this pilot study. I believe it is not so. If it is, please specify. If not, argue for why the mentioned alpha value is relevant. 14. Instruments section: When describing the ARE you mention alpha.90 for men and women. In my reading of the referred paper, the alphas does not seem to be the same as once reported here. Further, I do not know if it is the abbreviated version that you are going to use that is presented there. and possibly not the reworded one you are going to use. Please explain. 15. Instruments section: When presenting the SEPTI-TS no alpha values are presented, only that they are acceptable. They are presented in the referred study. 16. Instruments section: When presenting the ECR-RS you refer to an unpublished manuscript for alpha values. Do they not even have pre-prints? I suggest you at least write that you will provide alpha values when you have the data. The same is true for CSI-4. I would like a reason for why you chose to use measures that are not solely tested. 17. At page 12, I am presented with two additional research questions (in the instruments section of the manuscript). I would like them to be presented earlier. You also mention "the developers of the EFFT treatment protocol." Please specify which of the authors this refers to. You also state that the researchers will conduct the interviews. Can you tell me how many and possibly who they are? 18. Statistical Analysis Section: It is a good statistical model you are suggesting to use. However, it is a very complex model for a low-N pilot study. One suggestion would be to remove the dyadic level and use it as a predictor instead. My suggestion is based on the fact that the specified model with three levels uses two levels on time. Further, I agree that there are no agreed upon power analyses concerning multilevel models with three levels, but to argue that you therefore estimate power by using a repeated-measures ANOVA is not convincing. One option is to simulate or use STATA to do the power analysis. Why not plan to run a repeated measures ANOVA on this pilot study and then only test the three-level multilevel analysis in this pilot study to prepare for a later large scale study? Further, I find the numbers you are using in the power analysis to be very optimistic. It is better to plan a study from a less optimistic perspective. You refer to two studies with large effect sizes. Reference no. 35 is a large study of ABFT (n = 341) that uses other measures than those used in this study. The high effect size stems from the self-reported suicidal ideation measure. Please provide an argument for why it is relevant. Reference no. 36 is a pilot study with only 11 participants in the treatment group (ABFT), and the effect size of 1.08 was only for one of the measures (the HAM-D). Again, please provide an argument for its relevance. 19. I did not get access to the SPIRIT diagram. 20. The authors state that the data will be made publicly available, but not where. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-22-28187R1Effectiveness and feasibility of structured emotionally focused family therapy for parents and adolescents: Protocol of a within-subjects pilot studyPLOS ONE Dear Dr. Conradi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please respond in detail to each of the reviewer's remaining comments. Please submit your revised manuscript by May 05 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Kymberly D. Young, Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field. Reviewer #1: Yes ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses? The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory. Reviewer #1: Yes ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable? Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible. Reviewer #1: Yes ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I am pleased with how the authors addressed the majority of my initial comments. I apologize for not being explicit enough in a few of my initial comments and will clarify them so that the authors can comment and/or revise. Comment 3 There are two interventions with the abbreviation EFFT. The Encyclopedia of Couple and Family Therapy presents the two in consecutive chapters. Emotionally focused family therapy by Furrow and Palmer and Emotion-focused family therapy by Sabey and Lafrance are the two distinct EFFTs. Many years of research support the latter. See e.g., https://efftinternational.org/research. Since these two EFFTs are available today and the latter has been investigated for a number of years, I would propose that you include a section in the manuscript that comments on this so that the readers are informed and there is no misunderstanding as to which EFFT you intend to explore. If you do not include any of the research on that EFFT in your manuscript, you should also provide a reason why it is not relevant. Comment 11 I appreciate your clarification. I want to confirm that I and future readers have correctly understood your meaning. Do you intend to exclude any children or parents who are undergoing therapy for whatever reason? Comment 20 Under the guidelines for me as a reviewer, PLOS ONE asks, "Have the authors described where all data underlying the findings will be made available when the study is complete?"Since you have not stated WHERE it will be made available, I have to answer "no" to that question. I suggest you state where it is supposed to be publicly stored. One suggestion is osf.io, and another is data.mendeley.com, but you are free to choose any other repositories. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Rune Zahl-Olsen ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Effectiveness and feasibility of structured emotionally focused family therapy for parents and adolescents: Protocol of a within-subjects pilot study PONE-D-22-28187R2 Dear Dr. Conradi, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Kymberly D. Young, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-22-28187R2 Effectiveness and feasibility of structured emotionally focused family therapy for parents and adolescents: Protocol of a within-subjects pilot study Dear Dr. Conradi: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Kymberly D. Young Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .